Label: BUPRENORPHINE injection, solution

  • NDC Code(s): 70022-001-10
  • Packager: PAYLESS COMPOUNDERS, LLC
  • Category: ANIMAL COMPOUNDED DRUG
  • DEA Schedule: CIII
  • Marketing Status: unapproved drug other

Drug Label Information

Updated October 29, 2015

If you are a consumer or patient please visit this version.

View All Sections
  • PRINCIPAL DISPLAY PANEL

    Buprenorphine MDV 0.3mg/mL
  • INGREDIENTS AND APPEARANCE
    BUPRENORPHINE 
    buprenorphine injection, solution
    Product Information
    Product TypeANIMAL COMPOUNDED DRUGItem Code (Source)NDC:70022-001
    Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUSDEA ScheduleCIII    
    Reporting Period20151029-20160429
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BUPRENORPHINE HYDROCHLORIDE (UNII: 56W8MW3EN1) (BUPRENORPHINE - UNII:40D3SCR4GZ) BUPRENORPHINE0.3 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS DEXTROSE (UNII: 5SL0G7R0OK)  
    MANNITOL (UNII: 3OWL53L36A)  
    WATER (UNII: 059QF0KO0R)  
    HYDROCHLORIC ACID (UNII: QTT17582CB)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70022-001-1010 mL in 1 VIAL, MULTI-DOSE; Number of Units = 10
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other09/11/2015
    Labeler - PAYLESS COMPOUNDERS, LLC (031728341)
    Establishment
    NameAddressID/FEIBusiness Operations
    PAYLESS COMPOUNDERS, LLC604160239outsourcing animal drug compounding
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events (Animal Drug), FDA Safety Recalls (Animal Drug)

Related Resources

Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!